TABLE 2.
Multivariable Predictors of Post-LT Mortality and HCC Recurrence
| Predictor Variables | HR | 95% CI | P Value |
|---|---|---|---|
|
| |||
| Post-LT mortality | |||
| AFP at LT category | |||
| <100 ng/mL | Reference | ||
| 100 to 499 ng/mL | 1.07 | 0.83–1.38 | 0.53 |
| ≥500 ng/mL | 1.50 | 1.07–2.10 | 0.02 |
| 1-value | 1.13 | 0.91–1.39 | 0.27 |
| CTP class at LT | |||
| A | Reference | ||
| B | 1.33 | 1.11–1.59 | 0.002 |
| C | 1.64 | 1.33–2.03 | <0.001 |
| Age, per year | 1.03 | 1.01–1.03 | <0.001 |
| Race/ethnicity | |||
| Caucasian | Reference | ||
| Black | 1.08 | 0.87–1.35 | 0.70 |
| Hispanic | 0.84 | 0.67–1.06 | 0.14 |
| Asian | 0.66 | 0.48–0.89 | 0.007 |
| Other | 1.27 | 0.65–2.46 | 0.49 |
| DRI | 1.37 | 1.13–1.66 | 0.001 |
| Tumor diameter at LT, per cm | 1.11 | 1.06–1.17 | <0.001 |
| Post-LT HCC recurrence | |||
| AFP at LT category | |||
| <100 ng/mL | Reference | ||
| 100 to 499 ng/mL | 1.52 | 1.04–2.22 | 0.03 |
| ≥500 ng/mL | 1.88 | 1.13–3.14 | 0.02 |
| 1-value | 1.22 | 0.87–1.71 | 0.26 |
| Age at listing, per year | 1.02 | 1.00–1.03 | 0.03 |
| Sex | |||
| Male | Reference | ||
| Female | 0.71 | 0.53–0.95 | 0.02 |
| Race/ethnicity | |||
| Caucasian | Reference | ||
| Black | 0.63 | 0.42–0.94 | 0.02 |
| Hispanic | 0.93 | 0.67–1.28 | 0.65 |
| Asian | 0.51 | 0.31–0.83 | 0.008 |
| Other | 0.58 | 0.14–2.36 | 0.45 |
| Tumor diameter at LT, per cm | 1.15 | 1.07–1.23 | <0.001 |